Pulmonary arterial hypertension (PAH), i.e. high blood pressure in the lung, is a lethal condition. Novel therapies have shown promising pressure-lowering results, but their exact effects are unknown.
Pulmonary arterial hypertension (PAH) is a devastating disease characterized by progressive vascular remodeling and elevated pulmonary pressure, leading to right heart failure and high mortality, agai
The report on North America Iloprost covers a summarized study of several factors supporting market growth, such as market size, market type, major regions, and end-user applications. The report enabl
Pulmonary hypertension (PH) is a life-threatening condition with high mortality, categorized into Group 1-5 by distinct etiologies. Fasudil, a potent vasodilator targeting RhoA/Rho kinase pathway, hol
Report of Chronic Pulmonary Hypertension Drug Market is covering the summarized study of several factors encouraging the growth of the market such as market size, market type, major regions and end us
